Dimensional Fund Advisors LP grew its position in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 7.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,107,278 shares of the health services provider’s stock after acquiring an additional 141,362 shares during the quarter. Dimensional Fund Advisors LP owned about 3.86% of Maximus worth $135,084,000 as of its most recent filing with the SEC.
Several other institutional investors have also modified their holdings of MMS. Seizert Capital Partners LLC bought a new position in Maximus in the 4th quarter worth approximately $1,863,000. Ruffer LLP acquired a new stake in Maximus in the 4th quarter valued at about $6,951,000. UBS Group AG lifted its holdings in Maximus by 76.8% in the 4th quarter. UBS Group AG now owns 610,354 shares of the health services provider’s stock valued at $52,686,000 after acquiring an additional 265,095 shares during the last quarter. Comerica Bank boosted its position in shares of Maximus by 124.4% during the 4th quarter. Comerica Bank now owns 61,284 shares of the health services provider’s stock valued at $5,290,000 after purchasing an additional 33,973 shares in the last quarter. Finally, Fifth Third Bancorp boosted its position in shares of Maximus by 11,500.2% during the 1st quarter. Fifth Third Bancorp now owns 67,281 shares of the health services provider’s stock valued at $4,313,000 after purchasing an additional 66,701 shares in the last quarter. Institutional investors own 97.21% of the company’s stock.
Maximus Stock Performance
MMS opened at $61.04 on Tuesday. The company has a quick ratio of 2.21, a current ratio of 2.21 and a debt-to-equity ratio of 0.87. The stock’s 50 day moving average price is $58.59 and its two-hundred day moving average price is $69.46. The firm has a market capitalization of $3.21 billion, a P/E ratio of 9.14 and a beta of 0.60. Maximus, Inc. has a 12-month low of $52.73 and a 12-month high of $100.00.
Maximus Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Friday, August 14th will be issued a $0.33 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.32 dividend on an annualized basis and a yield of 2.2%. Maximus’s dividend payout ratio is 19.76%.
Wall Street Analysts Forecast Growth
Several research analysts have issued reports on the stock. Zacks Research lowered shares of Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Weiss Ratings cut shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, May 20th. Finally, Wall Street Zen raised Maximus from a “hold” rating to a “buy” rating in a research note on Saturday, June 6th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company currently has a consensus rating of “Hold”.
Read Our Latest Research Report on Maximus
Maximus Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Featured Stories
- Five stocks we like better than Maximus
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
